241 related articles for article (PubMed ID: 18165782)
41. Efficacy and limitations of natural killer cell depletion in cyclophosphamide-induced tolerance.
Shimizu I; Tomita Y; Okano S; Iwai T; Kajiwara T; Onzuka T; Tominaga R
Surg Today; 2007; 37(1):24-9. PubMed ID: 17186341
[TBL] [Abstract][Full Text] [Related]
42. Prevention of early loss of transplanted islets in the liver of mice by adenosine.
Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y
Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680
[TBL] [Abstract][Full Text] [Related]
43. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
Liu YP; Li Z; Nador RG; Strober S
Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
[TBL] [Abstract][Full Text] [Related]
44. Infusion of donor hepatic non-parenchymal cells prolongs survival of skin allografts in mice: role of microchimerism and IL-4.
Ding XM; Xue WJ; Ji ZZ; Tian PX
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):34-7. PubMed ID: 17287163
[TBL] [Abstract][Full Text] [Related]
45. Importance of donor-derived lymphocytes in the protection of pancreaticoduodenal or islet grafts from recurrent autoimmunity: a role for RT6+NKR-P1+ T cells.
Tori M; Ito T; Kitagawa-Sakakida S; Nozawa M; Matsuda H; Shirakura R
Transplantation; 2000 Jul; 70(1):32-8. PubMed ID: 10919571
[TBL] [Abstract][Full Text] [Related]
46. Human interleukin-10 transduced fetal liver stem cells prolong survival of mouse skin and heart allografts.
Hase T; Chargui J; Inori F; Yoshimura R; Sembeil R; Nakatani T; Touraine JL
Transplant Proc; 2005; 37(1):287-8. PubMed ID: 15808621
[TBL] [Abstract][Full Text] [Related]
47. Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48.
Yang TY; Sun Y; Langnas AN; Zhao Y
Clin Immunol; 2003 Feb; 106(2):148-54. PubMed ID: 12672405
[TBL] [Abstract][Full Text] [Related]
48. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
49. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
[TBL] [Abstract][Full Text] [Related]
50. Tolerance induction through simultaneous double bone marrow transplantation with two-signal blockade.
Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kwon CH; Noh JH; Kim SJ
Immunol Lett; 2006 Feb; 102(2):215-21. PubMed ID: 16260045
[TBL] [Abstract][Full Text] [Related]
51. Drug-induced tolerance to allografts in mice. X. Augmentation of split tolerance in murine combinations disparate at both H-2 and non-H-2 antigens by the use of spleen cells from donors preimmunized with recipient antigens.
Mayumi H; Himeno K; Tokuda N; Fan JL; Nomoto K
Immunobiology; 1987 May; 174(3):274-91. PubMed ID: 3305319
[TBL] [Abstract][Full Text] [Related]
52. Induction of tolerance in a rat model of laryngeal transplantation.
Akst LM; Siemionow M; Dan O; Izycki D; Strome M
Transplantation; 2003 Dec; 76(12):1763-70. PubMed ID: 14688529
[TBL] [Abstract][Full Text] [Related]
53. The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft.
Suemitsu R; Yoshino I; Shoji F; Yamaguchi M; Tomita Y; Maehara Y
J Surg Res; 2004 Nov; 122(1):8-13. PubMed ID: 15522308
[TBL] [Abstract][Full Text] [Related]
54. Assessment of tolerance induction to cardiac allograft by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
Isobe M; Suzuki J; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
J Heart Lung Transplant; 1997 Nov; 16(11):1149-56. PubMed ID: 9402515
[TBL] [Abstract][Full Text] [Related]
55. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
[TBL] [Abstract][Full Text] [Related]
56. NK cells promote islet allograft tolerance via a perforin-dependent mechanism.
Beilke JN; Kuhl NR; Van Kaer L; Gill RG
Nat Med; 2005 Oct; 11(10):1059-65. PubMed ID: 16155578
[TBL] [Abstract][Full Text] [Related]
57. Cyclophosphamide-induced chimera-type tolerance to allografts: an overview of drug-induced immunological tolerance.
Mayumi H; Tokunaga K
Fukuoka Igaku Zasshi; 1990 Jan; 81(1):20-39. PubMed ID: 2182492
[TBL] [Abstract][Full Text] [Related]
58. Cyclophosphamide-induced tolerance in fully allogeneic heart transplantation in mice.
Matsuura A; Katsuno M; Suzuki Y; Ito T; Yasuura K; Abe T; Yoshikai Y
Cell Immunol; 1994 May; 155(2):501-7. PubMed ID: 8181080
[TBL] [Abstract][Full Text] [Related]
59. [Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival].
Su G; Zhao WZ; Chen JJ; Xu J; Qiao CH; Liu C; Sun ZQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1562-7. PubMed ID: 18819868
[TBL] [Abstract][Full Text] [Related]
60. Role of peripheral hemopoietic chimerism in achieving donor-specific tolerance in adult mice.
Maeda T; Eto M; Nishimura Y; Nomoto K; Kong YY; Nomoto K
J Immunol; 1993 Feb; 150(3):753-62. PubMed ID: 8423338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
